Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

A new regulatory approach to clinical device bridging

The development of drug-device combination products continues to evolve, with increasing attention on how clinical bridging between different delivery systems is handled. In this context, regulatory approaches that support more efficient and …

Biobased plastics in drug delivery: From material equivalence to systemic decarbonization

Biobased plastics can cut carbon without changing performance or regulatory status. In our latest blog, Nadine Kaufmann and Michael Schori explore how material equivalence, lifecycle thinking, and scale enable real decarbonization in drug delivery …

SmartPilot in focus – a conversation between Ypsomed and S3 Connected Health

Carolina Canapè, Business Development Lead Digital Health at Ypsomed, speaks with William Lyons, Marketing Director at S3 Connected Health, about the latest developments and shared achievements in the evolution of SmartPilot – Ypsomed’s digital …

Interview: Enhancing Clinical Trials with CliniPilot and Clear to Clinic Programme

In this exclusive interview, Dr Carolina Canapè and Roger Lüscher talk with ONdrugDelivery’s Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors …

Closing the loop: Designing the future of sustainable drug delivery devices

As pharma moves toward net zero, device sustainability is under the spotlight. In our latest blog, Thuysi Dao outlines a two-pronged approach that combines sustainable device design with take-back and recycling possibilities – showcased through the …

SmartPilot - the first and only FDA-cleared connectivity solution for autoinjectors

SmartPilot is a digital add-on that transforms the YpsoMate autoinjector into a connected device. It automatically captures injection data, transmits it into the digital ecosystem, and transforms it into insights for patients, healthcare …

Self-injection device manufacturing in a dynamic world

How did pen-inspired injectors evolve into today’s flexible self-injection platforms? Discover the trends in usability, scale-up, and resilient manufacturing that are shaping the future of drug delivery in a fast-changing industry landscape.

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.

Sustainable GLP-1 drug delivery

GLP-1 therapies are entering a high-growth phase, driving demand for scalable, sustainable delivery solutions. As formulations evolve, device usability, and environmental impact becomes a key industry challenge.